This is the sort of night that reminds a team how fragile even a decent-looking rotation plan can be. Casey Mize was not just knocked out of Saturday’s start after 2 2/3 innings with a right ankle sprain; he was suddenly a problem San Diego did not need after trading for him at the deadline and trying to figure out what comes next.
The injury itself was awkward enough. Mize slipped on the steps entering the dugout after the second inning, tried to keep going in the third, got two outs, allowed a Ryan Jeffers double, and was then pulled. It is hardly the kind of sequence that inspires confidence, even if the early tests brought a small dose of relief. X-rays were negative, further imaging showed no structural damage, and he was considered day to day.
A rotation story that was already uneven
Mize’s brief Padres tenure has already been a mixed bag, and that is putting it kindly. Two duds, two quality starts: that is not a disastrous sample, but it is not exactly the profile of a pitcher who has settled in and taken command either. For a club that added him as part of a deadline reshuffle, the margin for inconvenience is thin. The trade chatter around him has already been plenty busy, from the move that brought him in to the broader rotation needs that kept his name in the spotlight, and now the immediate focus is simply on whether he can make his next turn at all.
The good news for San Diego is that the calendar is working in its favor. The Padres have a Thursday off-day, which could allow them to skip Mize’s next start without forcing an emergency fix. That matters, because Joe Musgrove is also said to be slated for one more minor league rehab outing before a possible return to San Diego’s rotation. In other words, the Padres may have just enough runway to absorb this without turning it into a crisis.
But let’s not pretend the concern disappears because the scans were clean. A pitcher who leaves after slipping on the dugout steps and then cannot finish the inning has still had his outing interrupted in the most annoying way possible. Mize is day to day, which is better than the alternative, yet it still leaves the Padres with a familiar headache: how to keep a rotation stable when the piece they just added is already under evaluation.
For now, the verdict is simple. The tests offered reassurance, but the start itself was a blunt reminder that Mize’s Padres story is still in its early, uncertain stage. One more setback, and the questions get louder very quickly.
